Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
European Journal of Pediatrics|November 26, 2022
A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencementYutaro Koyama, Masaru Miura, Tohru Kobayashi, et al.Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|June 18, 2002
Evolution of staged approach for Fontan operationHitoshi Yamauchi, Hajime Imura, Yuji Maruyama, et al.European Journal of Pediatrics|September 6, 2024
Regression effect of renin-angiotensin-aldosterone system inhibitors on Kawasaki disease patients with coronary artery aneurysm: a prospective, observational studyEisuke Suganuma, Masaru Miura, Yutaro Koyama, et al.Pediatric Research|August 6, 2004
Possible synergic effect of angiotensin-I converting enzyme gene insertion/deletion polymorphism and angiotensin-II type-1 receptor 1166A/C gene polymorphism on ischemic heart disease in patients with Kawasaki diseaseRyuji Fukazawa, Tomoyoshi Sonobe, Kunihiro Hamamoto, et al.Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|May 28, 2019
Interleukin-1beta Inhibition Attenuates Vasculitis in a Mouse Model of Kawasaki DiseaseYoshiaki Hashimoto, Ryuji Fukazawa, Noriko Nagi-Miura, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|September 1, 2017
Nationwide Survey of Patients With Giant Coronary Aneurysm Secondary to Kawasaki Disease 1999-2010 in JapanRyuji Fukazawa, Tohru Kobayashi, Masashi Mikami, et al.Brain & Development|September 3, 2008
An 8-year-old boy with vertebral artery dissection with cerebellar ataxia featuring suspected vertebral artery hypoplasiaYasuhiko Kawakami, Shin-ya Koizumi, Kentaro Kuwabara, et al.Journal of the American Heart Association|January 31, 2023
Analysis of Coronary Arterial Aneurysm Regression in Patients With Kawasaki Disease by Aneurysm Severity: Factors Associated With RegressionTaichi Kato, Masaru Miura, Tohru Kobayashi, et al.Lancet (London, England)|March 13, 2012
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trialTohru Kobayashi, Tsutomu Saji, Tetsuya Otani, et al.Plos One|January 21, 2016
Variations in ORAI1 Gene Associated with Kawasaki DiseaseYoshihiro Onouchi, Ryuji Fukazawa, Kenichiro Yamamura, et al.Pageof 6